SequelSEC

Electromedical Technologies, Inc EMED

Surgical & Medical Instruments & Apparatus · CIK 0001715819 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$922.01K
Fiscal year ended 2024-09-30
Operating income
-$1.01M
Fiscal year ended 2024-09-30
Free cash flow
Unavailable
Fiscal year ended 2024-09-30

Valuation, from the filing

Public float$1.33MMarket value of stock held by non-affiliates, as stated on the cover page for 2023-12-31
Float per share$0.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue1.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2023-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2023-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.13x4th
SBC / revenue53.0%87th
Gross margin77.5%86th
CapEx / revenue11.1%85th
Net margin-195.8%21th
FCF margin-116.2%24th
Operating margin-153.1%24th
Revenue YoY growth17.3%62th
R&D / revenue17.2%53th

Electromedical Technologies, Inc (EMED) reported revenue of $922.01K and net income of -$1.68M for the fiscal year ended 2024-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Electromedical Technologies, Inc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Electromedical Technologies, Inc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Revenue$922.01K
Cost of revenue$229.78K
Gross profit$692.23K
Operating income-$1.01M
Net income-$1.68M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$1.70M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Electromedical Technologies, Inc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Cash & equivalents$34.81K
Total assets$568.81K
Current assets$305.36K
Total liabilities$4.57M
Current liabilities$4.36M
Total equity incl. NCI-$4.00M
Temporary (mezzanine) equityUnavailable
Inventory$24.26K
Accounts receivable$7.25K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$225.81K

Cash flow

Electromedical Technologies, Inc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Operating cash flow-$131.21K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$27.54K
Net change in cash-$103.67K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$0

Derived

Electromedical Technologies, Inc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Free cash flowUnavailable
Gross margin75.1%
Operating margin-109.6%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.07x
Revenue YoY growth-35.1%
Net margin-182.0%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EMED in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2024-11-19View SEC filing
10-Q · Filed 2024-08-14View SEC filing
10-Q · Filed 2024-06-14View SEC filing
10-K · Filed 2024-05-01View SEC filing
10-Q · Filed 2023-11-20View SEC filing
10-Q · Filed 2023-08-21View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.